First‐line treatment of chronic hepatitis B with entecavir or tenofovir in 'real‐life'settings: from clinical trials to clinical practice
S Pol, P Lampertico - Journal of viral hepatitis, 2012 - Wiley Online Library
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first‐line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first‐line monotherapies for chronic hepatitis B. In Phase III trials …
First-line treatment of chronic hepatitis B with entecavir or tenofovir in'real-life'settings: from clinical trials to clinical practice
S Pol, P Lampertico - JOURNAL OF VIRAL HEPATITIS, 2012 - air.unimi.it
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
[HTML][HTML] First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life'settings: from clinical trials to clinical practice
S Pol, P Lampertico - Journal of Viral Hepatitis, 2012 - ncbi.nlm.nih.gov
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
First-line treatment of chronic hepatitis B with entecavir or tenofovir in'real-life'settings: from clinical trials to clinical practice.
S Pol, P Lampertico - 2012 - cabidigitallibrary.org
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
[PDF][PDF] First-line treatment of chronic hepatitis B with entecavir or tenofovir in Ôreal-lifeÕ settings: from clinical trials to clinical practice
S Pol, P Lampertico - Journal of Viral Hepatitis, 2012 - scienceopen.com
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
[PDF][PDF] First-line treatment of chronic hepatitis B with entecavir or tenofovir in Ôreal-lifeÕ settings: from clinical trials to clinical practice
S Pol, P Lampertico - Journal of Viral Hepatitis, 2012 - Citeseer
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
[PDF][PDF] First-line treatment of chronic hepatitis B with entecavir or tenofovir in Ôreal-lifeÕ settings: from clinical trials to clinical practice
S Pol, P Lampertico - Journal of Viral Hepatitis, 2012 - researchgate.net
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
First-line treatment of chronic hepatitis B with entecavir or tenofovir in'real-life'settings: from clinical trials to clinical practice.
S Pol, P Lampertico - Journal of Viral Hepatitis, 2012 - europepmc.org
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
First‐line treatment of chronic hepatitis B with entecavir or tenofovir in 'real‐life'settings: from clinical trials to clinical practice
S Pol, P Lampertico - Journal of Viral Hepatitis, 2012 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Summary.</jats: bold> Entecavir (ETV) and tenofovir disoproxil
fumarate (TDF) are potent nucleos (t) ide analogues (NUCs) recommended as first‐line …
fumarate (TDF) are potent nucleos (t) ide analogues (NUCs) recommended as first‐line …
First-line treatment of chronic hepatitis B with entecavir or tenofovir in'real-life'settings: from clinical trials to clinical practice
S Pol, P Lampertico - Journal of viral hepatitis, 2012 - pubmed.ncbi.nlm.nih.gov
Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos (t) ide analogues
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …
(NUCs) recommended as first-line monotherapies for chronic hepatitis B. In Phase III trials …